Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03650920 · ClinicalTrials.gov registry record · NA
Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients
A NA study, sponsored by Loma Linda University.
- Completed
- Registry status
- NA
- Development phase
- 89
- Enrollment target
NCT03650920: Completed NA study, sponsored by Loma Linda University.
NCT03650920 is a NA study that has completed, run by Loma Linda University. The registered enrollment target is 89 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03650920, a NA study, has completed, sponsored by Loma Linda University.
- COMPLETED
- Registry status
- NA
- Development phase
- 89 participants
- Enrollment target
Study Summary
To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.
Primary Outcome
Will track all subjects post transplant for 15 months
Interventions
- PROCEDURE Liver Transplantation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 89 participants |
| Start Date | 2018-09-02 |
| Est. Completion | 2021-02-19 |
| Phase | NA |
What the finished NCT03650920 record still lists
NCT03650920 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 89 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 1 intervention - of which Liver Transplantation is the first listed.
NCT03650920 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03650920 about?
NCT03650920 is a clinical study titled "Hepatitis C Virus (HCV) Positive Liver Grafts in HCV Negative Recipients". To provide proof-of-concept data on the efficacy/safety of transplanting HCV positive donor grafts in HCV sero-negative liver recipients who are currently listed.
What is the current status of trial NCT03650920?
This trial is currently completed. It is a NA study. The enrollment target is 89 participants. The study started on 2018-09-02. Estimated completion is 2021-02-19.
What interventions are being tested in trial NCT03650920?
The interventions under investigation include: Liver Transplantation (PROCEDURE).
Who is sponsoring clinical trial NCT03650920?
This trial is sponsored by Loma Linda University, which has 237 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03650920's enrollment target sits among peer trials
89 972nd of 2000 higher than 1,029 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03682289 · 89 participants · Phase 2
Ceralasertib (AZD6738) Alone and in Combination With Olaparib or Durvalumab in Patients With Solid Tumors
- NCT04787939 · 89 participants · NA
Early Feeding After Oral Cavity Reconstruction
- NCT05480449 · 89 participants · Phase 1
Autologous HuCART19 T Cells Manufactured Using the CliniMACS Prodigy Platform for Pediatric B-ALL (huCART19 Prodigy)
- NCT05604131 · 89 participants · Phase 2
Cardiac MRI-guided Deferiprone Therapy for Acute Myocardial Infarction Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI